UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 72

Sortiert nach

The Thermogenic Effect of Leptin Is Dependent on a Distinct Population of Prolactin-Releasing Peptide Neurons in the Dorsomedial Hypothalamus

Cell metabolism, 2014-10, Vol.20 (4), p.639-649

2014

Link zum Volltext

Verfügbarkeit prüfen

The hypothalamic RFamide, QRFP, increases feeding and locomotor activity: The role of Gpr103 and orexin receptors

PloS one, 2022-10, Vol.17 (10), p.e0275604-e0275604

2022

Link zum Volltext

Verfügbarkeit prüfen

The current state of GPCR‐based drug discovery to treat metabolic disease

British journal of pharmacology, 2018-11, Vol.175 (21), p.4060-4071

2018

Link zum Volltext

Verfügbarkeit prüfen

The biology of Nociceptin/Orphanin FQ(N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence

Pharmacology & therapeutics (Oxford), 2014-03, Vol.141 (3), p.283-299

2014

Link zum Volltext

Verfügbarkeit prüfen

Genetic Deletion of the Nociceptin/Orphanin FQ Receptor in the Rat Confers Resilience to the Development of Drug Addiction

Neuropsychopharmacology (New York, N.Y.), 2017-02, Vol.42 (3), p.695-706

2017

Link zum Volltext

Verfügbarkeit prüfen

A Model of Binge-Like Eating Behavior in Mice That Does Not Require Food Deprivation or Stress

Obesity (Silver Spring, Md.), 2010-09, Vol.18 (9), p.1710-1717

2010

Link zum Volltext

Verfügbarkeit prüfen

A Novel Nociceptin Receptor Antagonist LY2940094 Inhibits Excessive Feeding Behavior in Rodents: A Possible Mechanism for the Treatment of Binge Eating Disorder

The Journal of pharmacology and experimental therapeutics, 2016-02, Vol.356 (2), p.493

2016

Link zum Volltext

Verfügbarkeit prüfen

Mice lacking δ‐opioid receptors resist the development of diet‐induced obesity

The FASEB journal, 2012-08, Vol.26 (8), p.3483-3492

2012

Link zum Volltext

Verfügbarkeit prüfen

Occupancy of Nociceptin/Orphanin FQ Peptide Receptors by the Antagonist LY2940094 in Rats and Healthy Human Subjects

Drug metabolism and disposition, 2016-09, Vol.44 (9), p.1536-1542

2016

Link zum Volltext

Verfügbarkeit prüfen

A Novel, Orally Bioavailable Nociceptin Receptor Antagonist, LY2940094, Reduces Ethanol Self-Administration and Ethanol Seeking in Animal Models

Alcoholism, clinical and experimental research, 2016-05, Vol.40 (5), p.945-954

2016

Link zum Volltext

Verfügbarkeit prüfen

Discovery of a Novel Series of Orally Active Nociceptin/Orphanin FQ (NOP) Receptor Antagonists Based on a Dihydrospiro(piperidine-4,7′-thieno[2,3‑c]pyran) Scaffold

Journal of medicinal chemistry, 2014-04, Vol.57 (8), p.3418-3429

2014

Link zum Volltext

Verfügbarkeit prüfen

449. Preclinical Models for the Study of Binge Eating Disorder

Biological psychiatry (1969), 2017-05, Vol.81 (10), p.S183-S183

Statnick, Michael

2017

Link zum Volltext

Verfügbarkeit prüfen

Preclinical Models for the Study of Binge Eating Disorder

Biological psychiatry (1969), 2017, Vol.81 (10), p.S183-S183

Statnick, Michael

2017

Link zum Volltext

Verfügbarkeit prüfen

An Allosteric Potentiator of the Dopamine D1 Receptor Increases Locomotor Activity in Human D1 Knock-In Mice without Causing Stereotypy or Tachyphylaxis

The Journal of pharmacology and experimental therapeutics, 2017-01, Vol.360 (1), p.117

2017

Link zum Volltext

Verfügbarkeit prüfen

Discovery of Aminobenzyloxyarylamides as κ Opioid Receptor Selective Antagonists: Application to Preclinical Development of a κ Opioid Receptor Antagonist Receptor Occupancy Tracer

Journal of medicinal chemistry, 2011-12, Vol.54 (23), p.8000-8012

2011

Link zum Volltext

Verfügbarkeit prüfen

Regulation of Endogenous (Male) Rodent GLP-1 Secretion and Human Islet Insulin Secretion by Antagonism of Somatostatin Receptor 5

Endocrinology (Philadelphia), 2017-11, Vol.158 (11), p.3859-3873

2017

Link zum Volltext

Verfügbarkeit prüfen

κ‐Opioid receptors control the metabolic response to a high‐energy diet in mice

The FASEB journal, 2010-04, Vol.24 (4), p.1151-1159

2010

Link zum Volltext

Verfügbarkeit prüfen

Nociceptin/orphanin FQ suppresses the excitability of neurons in the ventromedial nucleus of the hypothalamus

The Journal of physiology, 2011-07, Vol.589 (13), p.3103-3114

2011

Link zum Volltext

Verfügbarkeit prüfen

Development of LC-MS/MS-Based Receptor Occupancy Tracers and Positron Emission Tomography Radioligands for the Nociceptin/Orphanin FQ (NOP) Receptor

Journal of medicinal chemistry, 2012-06, Vol.55 (11), p.4955-4967

2012

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and Evaluation of Radioligands for Imaging Brain Nociceptin/Orphanin FQ Peptide (NOP) Receptors with Positron Emission Tomography

Journal of medicinal chemistry, 2011-04, Vol.54 (8), p.2687-2700

2011

Link zum Volltext

Verfügbarkeit prüfen

Consequences of constitutive deletion of melanin-concentrating hormone-1 receptors for feeding and foraging behaviors of mice

Behavioural brain research, 2017-01, Vol.316, p.271-278

2017

Link zum Volltext

Verfügbarkeit prüfen

Determining pharmacological selectivity of the kappa opioid receptor antagonist LY2456302 using pupillometry as a translational biomarker in rat and human

The international journal of neuropsychopharmacology, 2015-01, Vol.18 (2), p.1-11

2015

Link zum Volltext

Verfügbarkeit prüfen

GH-Releasing Peptide-2 Increases Fat Mass in Mice Lacking NPY: Indication for a Crucial Mediating Role of Hypothalamic Agouti-Related Protein

Endocrinology (Philadelphia), 2002-02, Vol.143 (2), p.558-568

2002

Link zum Volltext

Verfügbarkeit prüfen

Genetic ablation of myelin protein zero-like 3 in mice increases energy expenditure, improves glycemic control, and reduces hepatic lipid synthesis

American journal of physiology: endocrinology and metabolism, 2013-07, Vol.305 (2), p.E282-E292

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(66)

Publikationsform

Artikel
(70)
Dissertationen
(2)

Sprache

Englisch
(72)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(45)
Life Sciences & Biomedicine
(43)
Animals
(41)
Male
(27)
Rats
(25)
Pharmacology & Pharmacy
(24)
Humans
(20)
Biological And Medical Sciences
(16)
Mice
(16)
Medical Sciences
(13)
Cho Cells
(11)
Cricetinae
(10)
Mice, Knockout
(10)
Narcotic Antagonists - Pharmacology
(10)
Neurosciences
(10)
Obesity
(10)
Neurosciences & Neurology
(9)
Dose-Response Relationship, Drug
(8)
Endocrinology & Metabolism
(8)
Pharmacology. Drug Treatments
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Thermogenic Effect of Leptin Is Dependent on a Distinct Population of Prolactin-Releasing Peptide Neurons in the Dorsomedial Hypothalamus

The hypothalamic RFamide, QRFP, increases feeding and locomotor activity: The role of Gpr103 and orexin receptors

The current state of GPCR‐based drug discovery to treat metabolic disease

The biology of Nociceptin/Orphanin FQ(N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence

LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders

Genetic Deletion of the Nociceptin/Orphanin FQ Receptor in the Rat Confers Resilience to the Development of Drug Addiction

A Model of Binge-Like Eating Behavior in Mice That Does Not Require Food Deprivation or Stress

A Novel Nociceptin Receptor Antagonist LY2940094 Inhibits Excessive Feeding Behavior in Rodents: A Possible Mechanism for the Treatment of Binge Eating Disorder

Mice lacking δ‐opioid receptors resist the development of diet‐induced obesity

Occupancy of Nociceptin/Orphanin FQ Peptide Receptors by the Antagonist LY2940094 in Rats and Healthy Human Subjects

A Novel, Orally Bioavailable Nociceptin Receptor Antagonist, LY2940094, Reduces Ethanol Self-Administration and Ethanol Seeking in Animal Models

Discovery of a Novel Series of Orally Active Nociceptin/Orphanin FQ (NOP) Receptor Antagonists Based on a Dihydrospiro(piperidine-4,7′-thieno[2,3‑c]pyran) Scaffold

449. Preclinical Models for the Study of Binge Eating Disorder

Preclinical Models for the Study of Binge Eating Disorder

An Allosteric Potentiator of the Dopamine D1 Receptor Increases Locomotor Activity in Human D1 Knock-In Mice without Causing Stereotypy or Tachyphylaxis

Discovery of Aminobenzyloxyarylamides as κ Opioid Receptor Selective Antagonists: Application to Preclinical Development of a κ Opioid Receptor Antagonist Receptor Occupancy Tracer

Regulation of Endogenous (Male) Rodent GLP-1 Secretion and Human Islet Insulin Secretion by Antagonism of Somatostatin Receptor 5

κ‐Opioid receptors control the metabolic response to a high‐energy diet in mice

Nociceptin/orphanin FQ suppresses the excitability of neurons in the ventromedial nucleus of the hypothalamus

Development of LC-MS/MS-Based Receptor Occupancy Tracers and Positron Emission Tomography Radioligands for the Nociceptin/Orphanin FQ (NOP) Receptor

Synthesis and Evaluation of Radioligands for Imaging Brain Nociceptin/Orphanin FQ Peptide (NOP) Receptors with Positron Emission Tomography

Consequences of constitutive deletion of melanin-concentrating hormone-1 receptors for feeding and foraging behaviors of mice

Determining pharmacological selectivity of the kappa opioid receptor antagonist LY2456302 using pupillometry as a translational biomarker in rat and human

GH-Releasing Peptide-2 Increases Fat Mass in Mice Lacking NPY: Indication for a Crucial Mediating Role of Hypothalamic Agouti-Related Protein

Genetic ablation of myelin protein zero-like 3 in mice increases energy expenditure, improves glycemic control, and reduces hepatic lipid synthesis

Suchergebnisse filtern